8 research outputs found
Serological Markers of Hepatitis-B In Hospital Staff
SYMP ON PROGRESS IN HEPATITIS B IMMUNIZATION -- MAY 03-05, 1989 -- PALAIS CONGRES, PARIS, FRANCEWOS: A1990BQ74Q00125INSERM, WHO, MINIST SANTE FRANCE, MINIST EDUC NATL JEUNESSE & SPORTS FRANCE, MINIST COOPERAT & DEV FRANC
Serological Markers of Hepatitis-B In the Personnel and Senior Students of Dentistry In a Dental Clinic
SYMP ON PROGRESS IN HEPATITIS B IMMUNIZATION -- MAY 03-05, 1989 -- PALAIS CONGRES, PARIS, FRANCEWOS: A1990BQ74Q00124INSERM, WHO, MINIST SANTE FRANCE, MINIST EDUC NATL JEUNESSE & SPORTS FRANCE, MINIST COOPERAT & DEV FRANC
Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains
Recently, an extended-spectrum beta -lactamase (PER-I) was found to be disseminated among Acinetobacter spp, and Pseudomonas aeruginosa isolates in Turkey. A population-based cohort study was conducted to elucidate predictive mortality factors in patients with nosocomial infections caused by Acinetobacter spp. and P. aeruginosa, with particular reference to PER-1-type extended-spectrum beta -lactamase (ESBL) production. The study group comprised 16 and 21 non-survivors and 82 and 126 survivors in cohorts infected with Acinetobacter and E. aeruginosa, respectively. In the Acinetobacter-infected cohort, nosocomial pneumonia, hypotension and infection with a PER-positive isolate were independent predictors of mortality. In the P. aeruginosa-infected cohort, impaired consciousness, a PER-positive isolate, male sex and (with a negative relative risk) urinary tract infection were independent predictors of death. This study demonstrated the relationship of PER-1-type ESBL-producing Acinetobacter spp. and P. aeruginosa with poor clinical outcome
Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains
WOS: 000169534300010PubMed ID: 11444775Recently, an extended-spectrum beta -lactamase (PER-I) was found to be disseminated among Acinetobacter spp, and Pseudomonas aeruginosa isolates in Turkey. A population-based cohort study was conducted to elucidate predictive mortality factors in patients with nosocomial infections caused by Acinetobacter spp. and P. aeruginosa, with particular reference to PER-1-type extended-spectrum beta -lactamase (ESBL) production. The study group comprised 16 and 21 non-survivors and 82 and 126 survivors in cohorts infected with Acinetobacter and E. aeruginosa, respectively. In the Acinetobacter-infected cohort, nosocomial pneumonia, hypotension and infection with a PER-positive isolate were independent predictors of mortality. In the P. aeruginosa-infected cohort, impaired consciousness, a PER-positive isolate, male sex and (with a negative relative risk) urinary tract infection were independent predictors of death. This study demonstrated the relationship of PER-1-type ESBL-producing Acinetobacter spp. and P. aeruginosa with poor clinical outcome